Browsing Tag
Armata Pharmaceuticals
1 post
Positive IDWeek 2025 results highlight Armata’s AP-SA02 phage cocktail as a potential game-changer for Staph bacteremia
Find out how Armata Pharmaceuticals’ AP-SA02 phage therapy could redefine treatment for Staphylococcus aureus bloodstream infections.